7-Day MEMO Patch Monitoring for Arrhythmia Detection in Patients With Palpitations
NCT: NCT07728552 · COMPLETED
Brief Summary
"This exploratory prospective clinical study aims to evaluate the diagnostic yield of a 7-day adhesive electrocardiographic (ECG) monitoring device (MEMO Patch) in detecting cardiac arrhythmias in patients presenting with palpitations. Participants who require 24-hour Holter monitoring because of symptoms such as palpitations or dizziness will simultaneously wear a conventional 24-hour Holter monitor and the MEMO Patch. The Holter monitor will be removed after 24 hours, while the MEMO Patch will continue monitoring for a total of 7 days. ECG recordings will be evaluated by cardiologists after technical quality assessment. The study will assess arrhythmia detection, device-related skin adverse events, and participant usability and satisfaction."
Frequently Asked Questions
What is 7-Day MEMO Patch Monitoring for Arrhythmia Detection in Patients With Palpitations?
7-Day MEMO Patch Monitoring for Arrhythmia Detection in Patients With Palpitations is a clinical trial registered under NCT07728552. Current status: COMPLETED.
What is the status of NCT07728552?
The current status of NCT07728552 (7-Day MEMO Patch Monitoring for Arrhythmia Detection in Patients With Palpitations) is: COMPLETED.
When did 7-Day MEMO Patch Monitoring for Arrhythmia Detection in Patients With Palpitations start?
7-Day MEMO Patch Monitoring for Arrhythmia Detection in Patients With Palpitations started on 2020-03-02.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.